ProQR Therapeutics N.V. (NASDAQ: PRQR)
$3.6100
N/A ( +0.28% ) 199.4K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Market Data
Open
$3.6100
Previous close
$3.6100
Volume
199.4K
Market cap
$298.07M
Day range
$3.6000 - $3.6590
52 week range
$1.1800 - $4.6200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 70 | Nov 07, 2024 |
| 6-k | Form 6-K | 6 | Oct 25, 2024 |
| 6-k | Form 6-K | 70 | Aug 08, 2024 |
| 6-k | Form 6-K | 1 | May 22, 2024 |
| 6-k | Form 6-K | 72 | May 09, 2024 |
| 6-k | Form 6-K | 2 | May 08, 2024 |
| 6-k | Form 6-K | 9 | Apr 23, 2024 |
| 6-k | Form 6-K | 2 | Apr 19, 2024 |
| 6-k | Form 6-K | 2 | Mar 13, 2024 |
| 20-f | Annual reports | 122 | Mar 13, 2024 |